ADHD Research Today is a free monthly online journal that collates and summarizes the latest research about ADHD, including details on attention-deficit hyperactivity disorder, drugs, treatment, symptoms.

Volume 2 (2005), Issue 6 (June)

1. Adaptive, emotional, and family functioning of children with obsessive-compulsive disorder and comorbid attention deficit hyperactivity disorder.
   Am J Psychiatry, 162(6): 1125-32. [Abstract] [Full-text]
2. Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects.
   Am J Psychiatry, 162(6): 1083-9. [Abstract] [Full-text]
3. Inhibition of motor responses in siblings concordant and discordant for attention deficit hyperactivity disorder.
   Am J Psychiatry, 162(6): 1076-82. [Abstract] [Full-text]
4. Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD.
   Am J Psychiatry, 162(6): 1067-75. [Abstract] [Full-text]
5. Dysthymic disorder contributes to oppositional defiant behaviour in children with Attention Deficit Hyperactivity Disorder, combined type (ADHD-CT).
   J Affect Disord, 86(2): 329-33. [Abstract] [Full-text]
6. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
   Arch Pediatr Adolesc Med, 159(6): 572-8. [Abstract] [Full-text]
7. The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD.
   Exp Brain Res, 163(3): 352-60. [Abstract] [Full-text]
8. A possible antienuretic effect of reboxetine in children and adolescents with attention deficit/hyperactivity disorder: case series.
   Neuropsychobiology, 51(4): 239-42. [Abstract] [Full-text]
9. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
   Exp Clin Psychopharmacol, 13(2): 111-26. [Abstract] [Full-text]
10. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Biol Psychiatry, 57(11): 1467-73. [Abstract] [Full-text]
11. A family based study implicates solute carrier family 1-member 3 (SLC1A3) gene in attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1461-6. [Abstract] [Full-text]
12. Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1452-60. [Abstract] [Full-text]
13. Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication.
    Biol Psychiatry, 57(11): 1442-51. [Abstract] [Full-text]
14. Attention-deficit/hyperactivity disorder in a diverse culture: do research and clinical findings support the notion of a cultural construct for the disorder?
    Biol Psychiatry, 57(11): 1436-41. [Abstract] [Full-text]
15. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade.
    Biol Psychiatry, 57(11): 1424-35. [Abstract] [Full-text]
16. Varieties of attention-deficit/hyperactivity disorder-related intra-individual variability.
    Biol Psychiatry, 57(11): 1416-23. [Abstract] [Full-text]
17. Imaging the effects of methylphenidate on brain dopamine: new model on its therapeutic actions for attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1410-5. [Abstract] [Full-text]
18. The dopamine transporter and attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1397-409. [Abstract] [Full-text]
19. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
    Biol Psychiatry, 57(11): 1391-6. [Abstract] [Full-text]
20. The neuropsychopharmacology of attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1385-90. [Abstract] [Full-text]
21. Attention-deficit/hyperactivity disorder pharmacogenomics.
    Biol Psychiatry, 57(11): 1367-73. [Abstract] [Full-text]
22. Principles of haplotype mapping and potential applications to attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1357-66. [Abstract] [Full-text]
23. Statistical approaches to complex phenotypes: evaluating neuropsychological endophenotypes for attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1347-56. [Abstract] [Full-text]
24. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review.
    Biol Psychiatry, 57(11): 1336-46. [Abstract] [Full-text]
25. Attention-deficit/hyperactivity disorder endophenotypes.
    Biol Psychiatry, 57(11): 1324-35. [Abstract] [Full-text]
26. Molecular genetics of attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1313-23. [Abstract] [Full-text]
27. In vivo neuroreceptor imaging in attention-deficit/hyperactivity disorder: a focus on the dopamine transporter.
    Biol Psychiatry, 57(11): 1293-300. [Abstract] [Full-text]
28. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1285-92. [Abstract] [Full-text]
29. Functional neuroimaging of attention-deficit/hyperactivity disorder: a review and suggested future directions.
    Biol Psychiatry, 57(11): 1273-84. [Abstract] [Full-text]
30. Structural brain imaging of attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1263-72. [Abstract] [Full-text]
31. A developmental perspective on the measurement of cognitive deficits in attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1256-60. [Abstract] [Full-text]
32. Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model.
    Biol Psychiatry, 57(11): 1248-55. [Abstract] [Full-text]
33. Rodent models of attention-deficit/hyperactivity disorder.
    Biol Psychiatry, 57(11): 1239-47. [Abstract] [Full-text]
34. Causal models of attention-deficit/hyperactivity disorder: from common simple deficits to multiple developmental pathways.
    Biol Psychiatry, 57(11): 1231-8. [Abstract] [Full-text]
35. Causal heterogeneity in attention-deficit/hyperactivity disorder: do we need neuropsychologically impaired subtypes?
    Biol Psychiatry, 57(11): 1224-30. [Abstract] [Full-text]
36. Attention-deficit/hyperactivity disorder: a selective overview.
    Biol Psychiatry, 57(11): 1215-20. [Abstract] [Full-text]
37. Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.
    Biol Psychiatry, 57(12): 1597-600. [Abstract] [Full-text]
38. How do children with attention deficit hyperactivity disorder interact in a clinical dental examination? A video analysis.
    Eur J Oral Sci, 113(3): 203-9. [Abstract] [Full-text]
39. Exploring clinician uncertainty in the diagnosis and treatment of attention deficit hyperactivity disorder.
    Sociol Health Illn, 27(3): 305-23. [Abstract] [Full-text]
40. Height, weight, IGF-I, IGFBP-3 and thyroid functions in prepubertal children with attention deficit hyperactivity disorder: effect of methylphenidate treatment.
    Horm Res, 63(4): 159-64. [Abstract] [Full-text]
41. Global consensus on ADHD/HKD.
    Eur Child Adolesc Psychiatry, 14(3): 127-37. [Abstract] [Full-text]
42. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
    Neuropsychopharmacology, 30(7): 1374-82. [Abstract] [Full-text]
43. Case definition in epidemiologic studies of AD/HD.
    Ann Epidemiol, 15(6): 430-7. [Abstract] [Full-text]
44. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD?
    J Child Psychol Psychiatry, 46(7): 774-803. [Abstract] [Full-text]
45. The impact of preschool inattention, hyperactivity, and impulsivity on social and academic development: a review.
    J Child Psychol Psychiatry, 46(7): 755-73. [Abstract] [Full-text]
46. Virtual reality in brain damage rehabilitation: review.
    Cyberpsychol Behav, 8(3): 241-62; discussion 263-71. [Abstract] [Full-text]
47. The adolescent outcome of hyperactive girls. Self-reported interpersonal relationships and coping mechanisms.
    Eur Child Adolesc Psychiatry, 14(5): 245-53. [Abstract] [Full-text]
48. Sex differences in adolescent ADHD: findings from concurrent EEG and EDA.
    Clin Neurophysiol, 116(6): 1455-63. [Abstract] [Full-text]
49. Changes in platelet monoamine oxidase activity, cholesterol levels and hyperactive behaviour in adolescents over a period of three years.
    Neurosci Lett, 384(3): 310-5. [Abstract] [Full-text]
50. The role of children's ethnicity in the relationship between teacher ratings of attention-deficit/hyperactivity disorder and observed classroom behavior.
    J Consult Clin Psychol, 73(3): 424-34. [Abstract] [Full-text]
51. What aspects of peer relationships are impaired in children with attention-deficit/hyperactivity disorder?
    J Consult Clin Psychol, 73(3): 411-23. [Abstract] [Full-text]

© 2004-2010 ADHD Research Today. All Rights Reserved.